We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+172.63%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$270M
AUM Growth
+$241M
Cap. Flow
+$131M
Cap. Flow %
48.43%
Top 10 Hldgs %
65.79%
Holding
91
New
53
Increased
2
Reduced
3
Closed
21

Top Buys

Rank Stock Value
1
NKLA
Nikola Corporation Common Stock
NKLA
+$16.1M
2
HECCU
Hudson Executive Investment Corp. Units
HECCU
+$12.2M
3
TME icon
Tencent Music
TME
+$11.8M
4
IIPR icon
Innovative Industrial Properties
IIPR
+$11.5M
5
TBIO
Translate Bio, Inc. Common Stock
TBIO
+$11.3M

Top Sells

Rank Stock Value
1
ENLV icon
Enlivex Ltd
ENLV
+$1.96M
2
DMK
DMK Pharmaceuticals Corporation Common Stock
DMK
+$1.21M
3
BXRX
Baudax Bio, Inc. Common Stock
BXRX
+$1.07M
4
IMNN icon
Imunon
IMNN
+$1.03M
5
PHIO icon
Phio Pharmaceuticals
PHIO
+$637K

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.18%
2 Healthcare 27.27%
3 Consumer Discretionary 15.45%
4 Communication Services 10.78%
5 Real Estate 4.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TELA icon
26
TELA Bio
TELA
$47.1M
$1.47M 0.54%
+113,043
New +$1.48M
CSTL icon
27
Castle Biosciences
CSTL
$1.06B
$1.4M 0.52%
+37,235
New +$1.27M
STEX
28
Streamex Corp
STEX
$68.8M
$1.32M 0.49%
+18,358
New +$1.6M
SOLY
29
DELISTED
Soliton, Inc.
SOLY
$1.29M 0.48%
+166,113
New +$1.63M
FRTX
30
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$1.28M 0.47%
+28,456
New +$1.52M
MBIO icon
31
Mustang Bio
MBIO
$3.86M
$1.17M 0.43%
+491
New +$1.15M
ATNM icon
32
Actinium Pharmaceuticals
ATNM
$39.3M
$1M 0.37%
+95,016
New +$720K
SONM icon
33
DNA X Inc
SONM
$4.39M
$811K 0.3%
+557
New +$890K
QUIK icon
34
QuickLogic
QUIK
$186M
$795K 0.29%
+259,940
New +$1.08M
MLSS icon
35
Milestone Scientific
MLSS
$36.7M
$731K 0.27%
+374,765
New +$686K
ACHV icon
36
Achieve Life Sciences
ACHV
$745M
$726K 0.27%
+91,463
New +$729K
KTOS icon
37
Kratos Defense & Security Solutions
KTOS
$9.08B
$669K 0.25%
+42,778
New +$685K
CRIS icon
38
Curis
CRIS
$2.76M
$660K 0.24%
+1,364
New +$503K
KLR
39
DELISTED
Kaleyra, Inc.
KLR
$625K 0.23%
+44,231
New +$991K
YTRA icon
40
Yatra Online
YTRA
$67.8M
$560K 0.21%
+824,320
New +$887K
GLBS icon
41
Globus Maritime Ltd
GLBS
$77M
$551K 0.2%
+20,624
New +$1.31M
TTPH
42
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$524K 0.19%
208,074
– –
KZR
43
DELISTED
Kezar Life Sciences
KZR
$486K 0.18%
+9,375
New +$473K
CANF
44
Can-Fite BioPharma American Depositary Shares
CANF
$4.86M
$392K 0.15%
+990
New +$364K
ASRT
45
DELISTED
Assertio
ASRT
$372K 0.14%
+7,238
New +$373K
ALT icon
46
Altimmune
ALT
$640M
$315K 0.12%
+29,400
New +$162K
CTRM icon
47
Castor Maritime
CTRM
$22.3M
$305K 0.11%
+7,613
New +$495K
RCON icon
48
Recon Technology
RCON
$548K
$305K 0.11%
+74
New +$658K
WINT
49
DELISTED
Windtree Therapeutics
WINT
$226K 0.08%
+1
New +$317K
CLRB icon
50
Cellectar Biosciences
CLRB
$22M
$179K 0.07%
+467
New +$196K
1
2
3 4

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q2 2020 Portfolio in Review

As of Q2 2020, CVI Holdings held 91 positions worth $270M, up 847% from $28.5M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

CVI Holdings deployed $131M of net new capital in Q2 2020, opening 53 new positions and adding to 2 existing holdings. Its largest new stake was Nikola Corporation Common Stock: 16,667 shares worth $33.8M.

By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 58% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Enlivex Ltd, an estimated $1.96M trimmed.

  • CVI Holdings's largest Q2 2020 buy was Nikola Corporation Common Stock: 16,667 shares worth $33.8M.
  • CVI Holdings added most to Replimune Group in Q2 2020, an estimated $2.26M increase.
  • CVI Holdings's biggest Q2 2020 reduction was Enlivex Ltd, cutting an estimated $1.96M.
  • CVI Holdings fully exited DMK Pharmaceuticals Corporation Common Stock in Q2 2020, selling an estimated $1.21M.
  • CVI Holdings's ten largest holdings make up 66% of its $270M portfolio in Q2 2020.
  • CVI Holdings opened 53 new positions and closed 21 in Q2 2020.
  • CVI Holdings's portfolio value rose 847% quarter-over-quarter to $270M.

Based on CVI Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.